Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,481 | -69,134 | -55,325 | -26,294 | -9,336 |
| Depreciation Amortization | 519 | 357 | 296 | 140 | 47 |
| Other Working Capital | -729 | 6,360 | -5,847 | -481 | 1,070 |
| Other Operating Activity | 16,917 | 12,278 | 10,591 | 2,890 | 456 |
| Operating Cash Flow | $-69,774 | $-50,139 | $-50,285 | $-23,745 | $-7,763 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -97,739 | -143,835 | N/A | N/A | N/A |
| PPE Investments | -664 | -770 | -559 | -645 | -312 |
| Investing Cash Flow | $-98,403 | $-144,605 | $-559 | $-645 | $-312 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -9 | -17 |
| Common Stock Issued | 202,557 | 1,537 | 632 | 181,734 | 140 |
| Other Financing Activity | -420 | 0 | 0 | 129,623 | 23,311 |
| Financing Cash Flow | $202,137 | $1,537 | $632 | $311,348 | $23,434 |
| Beginning Cash Position | 59,006 | 252,213 | 302,425 | 15,467 | 108 |
| End Cash Position | 92,966 | 59,006 | 252,213 | 302,425 | 15,467 |
| Net Cash Flow | $33,960 | $-193,207 | $-50,212 | $286,958 | $15,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,774 | -50,139 | -50,285 | -23,745 | -7,763 |
| Capital Expenditure | -664 | -770 | -559 | -661 | -312 |
| Free Cash Flow | -70,438 | -50,909 | -50,844 | -24,406 | -8,075 |